Systemic corticosteroids for community-acquired pneumonia: Reasons for use and lack of benefit on outcome

Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia

(2011) Dennis Chen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

(2011) Sabine CA Meijvis et al.   LANCET

Efficacy of Corticosteroids in Community-acquired Pneumonia

(2010) Dominic Snijders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Factors associated with inflammatory cytokine patterns in community-acquired pneumonia

(2010) R. Martinez et al.   EUROPEAN RESPIRATORY JOURNAL

Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia

(2010) R. Malo de Molina et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study

(2010) Jorge I.F. Salluh et al.   JOURNAL OF CRITICAL CARE

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia

(2009) P. Gutierrez et al.   EUROPEAN RESPIRATORY JOURNAL

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

(2009) R Menendez et al.   THORAX

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

(2009) W S Lim et al.   THORAX

Effects of glucocorticoids in ventilated piglets with severe pneumonia

(2008) O. Sibila et al.   EUROPEAN RESPIRATORY JOURNAL

Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease

(2008) M. Bradley Drummond et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Markers of treatment failure in hospitalised community acquired pneumonia

(2008) R Menendez et al.   THORAX